ID Name Structure References (top 5) Molecular Target(s)
1ID:511
ASTRAGALOSIDE IV


NSC#:650944

Freqency:
in 1 ingredients:

  • 233
  • in 42 recipes:

  • 47
  • 49
  • 58
  • 87
  • 91
  • 102
  • 107
  • 110
  • 115
  • 123
  • 131
  • 155
  • 156
  • 161
  • 170
  • 190
  • 203
  • 227
  • 244
  • 247
  • 271
  • 272
  • 280
  • 294
  • 301
  • 312
  • 338
  • 340
  • 351
  • 367
  • 382
  • 410
  • 438
  • 441
  • 443
  • 446
  • 448
  • 449
  • 458
  • 459
  • 515
  • 522

  • Properties
    C41H68O14    784.97





    1:  Zhang WJ, Wojta J, Binder BR.
    Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
    J Vasc Res.    impact factor:   2.71
    1997;  34(4): 273-80

    2:  Kao ST, Yeh CC, Hsieh CC, Yang MD, Lee MR, Liu HS, Lin JG.
    The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest.
    Life Sci.    impact factor:   1.774
    2001;  69(13): 1485-96

    3:  Li W, Fitzloff JF.
    Determination of astragaloside IV in Radix astragali (Astragalus membranaceus var. monghulicus) using high-performance liquid chromatography with evaporative light-scattering detection.
    J Chromatogr Sci.    impact factor:   1.199
    2001;  39(11): 459-62

    4:  Yao M, Qi Y, Bi K, Wang X, Luo X, Che C.
    A precolumn derivatization high-performance liquid chromatographic method with improved sensitivity and specificity for the determination of astragaloside IV in Radix Astragali.
    J Chromatogr Sci.    impact factor:   1.199
    2000;  38(8): 325-8

    5:  Abdallah RM, Ghazy NM, El-Sebakhy NA, Pirillo A, Verotta L.
    Astragalosides from Egyptian Astragalus spinosus Vahl.
    Pharmazie.    impact factor:   .446
    1993;  48(6): 452-4

    P450
     
    Time used: 422 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005